Consolidated and Combined Statements of Shareholders' Equity - USD ($) $ in Thousands |
Total |
Recro |
Parent Company Net Investment |
Parent Company Net Investment
Recro
|
Common Stock |
Additional Paid in Capital |
Accumulated Deficit |
|---|---|---|---|---|---|---|---|
| Balance at Dec. 31, 2017 | $ (62,457) | $ (62,457) | |||||
| Stock-based compensation expense | $ 4,574 | $ 4,574 | |||||
| Net transfer from parent company | 63,203 | 63,203 | |||||
| Net loss | (73,667) | (73,667) | |||||
| Balance at Dec. 31, 2018 | (68,347) | (68,347) | |||||
| Stock-based compensation expense | 499 | $ 4,964 | $ 4,964 | $ 499 | |||
| Issuance of common stock upon separation | $ 94 | (94) | |||||
| Issuance of common stock upon separation, Shares | 9,350,709 | ||||||
| Reclassification of parent company net investment | 33,480 | $ (33,480) | |||||
| Net transfer from parent company | 60,268 | 60,268 | |||||
| Contribution of cash by Recro Pharma,Inc. upon separation | 19,000 | 19,000 | |||||
| Separation-related adjustments | (548) | (548) | |||||
| Net loss | (32,557) | $ (30,365) | (2,192) | ||||
| Balance at Dec. 31, 2019 | $ (16,721) | $ 94 | $ 19,405 | $ (36,220) | |||
| Balance, Shares at Dec. 31, 2019 | 9,350,709 |
| X | ||||||||||
- Definition Adjustments to additional paid in capital contribution of cash received upon separation. No definition available.
|
| X | ||||||||||
- Definition Net transfer from parent. No definition available.
|
| X | ||||||||||
- Definition Reclassification of investment. No definition available.
|
| X | ||||||||||
- Definition Separation-related adjustments. No definition available.
|
| X | ||||||||||
- Definition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares issued which are neither cancelled nor held in the treasury. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|